Société Française d'Alcoologie

What Société Française d'Alcoologie does

Société Française d'Alcoologie et d'Addictologie (SF2A), formerly Société Française d'Alcoologie (SFA), is a French non-profit scientific society (association loi 1901) recognized as being of public utility since 1998 and headquartered at the Université Picardie Jules Verne in Amiens, co-located with the GRAP research laboratory. The society serves as the premier French authority on alcoology and addictology, serving two principal segments: healthcare professionals and researchers in alcoology/addictology, and the general public engaged through public health campaigns. Its portfolio includes the Alcool Conso Science (ACS) research communication project funded by the Caisse nationale de l'Assurance Maladie through the Fonds de Lutte Contre les Addictions, the Revue Alcoologie & Addictologie scientific journal, annual JSFA conferences, a webinar series, official clinical recommendations, and public-facing tools including the MyDéfi® mobile app supporting the Défi de Janvier campaign (used in a published BMC Medicine study with 2,032 users) and the Ethyloclic® clinical decision support platform modeled on Antibioclic for primary-care alcohol misuse screening.

The society's revenue model relies on individual membership subscriptions, conference and training registration fees, and project-based public-health grants, with the FLCA-funded ACS project representing a key institutional funding stream. It is led by President Pr Mickael Naassila (Professeur des Universités at UPJV, membre sénior of the Institut Universitaire de France) and Director Marie-Ange Testelin. Its go-to-market is community-led: engaging members through the sfalcoologie.fr portal, newsletters, Zoom-based webinars, annual scientific meetings, and high-visibility public campaigns, while operating as the French coordinating node in an international ecosystem that includes ISBRA, ESBRA, NIAAA, INSERM, OFDT, Santé publique France, Addictions France, and EUFASD. In 2025, the organization rebranded from SFA to SF2A to reflect an expanded mandate from alcoology into broader addictology, and is preparing to co-organize the 2027 World Congress on Alcohol Research in Paris with ISBRA and ESBRA.

Name

Société Française d'Alcoologie

Legal name

Société Française d'Alcoologie et d'Addictologie

Website

https://sfalcoologie.fr

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

1–10 employees

Short description

SF2A is a French non-profit scientific society (recognized of public utility since 1998) serving as the national authority on alcoology and addictology for healthcare professionals, researchers, and the general public through journals, conferences, webinars, and public health campaigns.

Ownership category

akta.pro rank

Product category

Medical Scientific Society Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Membership Organizations (8600)

akta.pro primary industry

Substance Use Prevention & Recovery Lifestyle Education (Non-clinical) (EDAAAHAL)

akta.pro secondary industries

Community Health, Health Promotion & Behavior Change (SBCC) (BPADAIAL), KOL Engagement & Medical Education (Advisory Boards/CME Support) (HLAGALAM)

Keywords

• Alcoology research
• Addiction medicine
• Clinical guidelines
• Public health campaigns
• Scientific society

Headquarters

HQ city

Amiens

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Membership Fees: The society operates through member subscriptions, with an online member portal for account management. Members include healthcare professionals, researchers, and stakeholders in alcoology and addictology.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

The Société Française d'Alcoologie et d'Addictologie (SF2A) is a French scientific society that synthesizes and disseminates evidence-based research on alcohol and addiction, publishes the Revue Alcoologie & Addictologie journal, issues clinical practice recommendations, and runs the Alcool Conso Science communication project. It delivers professional education through the annual Journées SF2A conference, ongoing webinars, and DPC workshops, and operates public health initiatives such as the Le Défi de Janvier campaign supported by the MyDéfi® mobile app and the Ethyloclic® clinical decision support platform.

Product overview

Société Française d'Alcoologie et d'Addictologie (SF2A) is a professional medical society that serves as a scientific authority on alcohol-related issues in France. The organization operates a portfolio of products and services centered around research dissemination, professional education, and public health campaigns. The core offerings include the Alcool Conso Science (ACS) research communication project, the Revue Alcoologie & Addictologie scientific journal, and clinical recommendations. Key public-facing tools include the MyDéfi® mobile application for the Défi de Janvier campaign and the Ethyloclic® medical decision support platform for primary care. The society also organizes annual JSFA conferences and regular webinars for continuing professional development.

Differentiator

Problem solved

Functional benefit

Brands

• Alcool Conso Science (ACS): Scientific communication project providing evidence-based information on alcohol consumption and health
• Le Défi de Janvier
• Journées SF2A (JSFA)
• Revue Alcoologie & Addictologie
• Ethyloclic

Quantifiable outcome

• Study published in BMC Medicine with 2,032 MyDéfi app users during Défi de Janvier 2024
• +2 more outcomes

Segments2 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Twelve partnerships are on record, tiered flagship, major, core and minor.

• ISBRA (International Society for Biomedical Research on Alcohol and Addiction)flagshipStrategic or Co-development Partner · 8 November 2027Co-organizer of the 2027 World Congress on Alcohol and Addictions research in Paris with ESBRA and SF2A, representing a flagship international collaboration.
• ESBRA (European Society for Biomedical Research on Alcohol)flagshipStrategic or Co-development Partner · 8 November 2027Co-organizer of the 2027 World Congress on Alcohol and Addictions research in Paris with ISBRA and SF2A, representing a flagship international collaboration.
• NIAAA (National Institute on Alcohol Abuse and Alcoholism)majorStrategic or Co-development Partner · 4 January 2025Collaborates on international research initiatives including the AMI on Harmonization of research metrics on alcohol use, with INSERM as a partner in supporting this initiative.
• INSERMmajorStrategic or Co-development Partner · 4 January 2025Partner in the NIAAA harmonization initiative and ongoing research collaborations on alcohol-related health issues, including expertise collective studies.
• Addictions FrancemajorStrategic or Co-development Partner · 1 January 2018Long-standing partner in public health initiatives, joint conferences, and prevention campaigns. Collaborated on events including the 2020 journées and various webinars.
• GRAP (Groupe de Recherche sur l'Alcool et les Pharmacodépendances)coreStrategic or Co-development PartnerThe society's headquarters are co-located with GRAP at Université Picardie Jules Verne in Amiens. GRAP is the primary research laboratory conducting alcoology research that informs the society's scientific activities.
• Université Picardie Jules VernecoreStrategic or Co-development PartnerHost institution for the society's headquarters and research activities, providing academic infrastructure and research collaboration opportunities.
• OFDT (Observatoire Français des Drogues et des Tendances Addictives)majorStrategic or Co-development PartnerCollaborates on research and data sharing regarding alcohol consumption statistics and trends in France. The OFDT provides epidemiological data that informs the society's public health work.
• Santé publique FrancemajorStrategic or Co-development PartnerCollaborates on public health campaigns including the Défi de Janvier and provides official consumption guidelines. The society supports and promotes Santé publique France recommendations.
• EUFASD (European Federation of FASD Associations)majorStrategic or Co-development PartnerCollaborates on European conferences regarding Fetal Alcohol Spectrum Disorders, with the next conference scheduled for 2026.
• SNFGE (Société Nationale des Maladies et Cancers de l'Appareil Digestif)majorStrategic or Co-development PartnerCollaborates on educational content including Tuto Gastro video series on alcohol and liver health, providing clinical expertise.
• ReuniraminorStrategic or Co-development PartnerNetwork partner referenced in the society's activities, working on addiction research and care coordination.

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• INSERM: French national institute of health and medical research, listed as a key SF2A partner. Comparable as a major public research authority in France that conducts and disseminates addiction-related research and expertise collective studies.
• Addictions France: Major French nonprofit addressing addiction prevention and care. Listed as a long-standing SF2A partner (since 2018) co-organizing events, webinars, and prevention campaigns in the same alcoology/addictology space.
• Santé publique France: France's national public health agency. A core SF2A partner that co-runs prevention campaigns (e.g., Défi de Janvier) and publishes official consumption guidelines; overlapping authority on French addiction prevention policy.
• OFDT (Observatoire Français des Drogues et des Tendances Addictives): French national observatory on drugs and addictive trends. A core SF2A partner providing epidemiological consumption data (e.g., 10.35 L/capita) used in SF2A's public health work.

Direct peers

• American Society of Addiction Medicine (ASAM): U.S. professional society for physicians specializing in addiction medicine. Closely comparable to SF2A as a membership-based learned society that issues clinical guidelines, publishes a journal, runs conferences, and advocates on alcohol/drug misuse.
• American Academy of Addiction Psychiatry (AAAP): U.S. medical specialty society focused on addiction psychiatry. Comparable to SF2A in producing clinical guidance, running CME webinars, and convening researchers/clinicians on substance use disorders.
• European Federation of Addiction Societies (EUFAS): Umbrella organization of European national addiction societies. SF2A is a member/partner; EUFAS plays a comparable convening role across European addiction societies, including alcoology.
• Société Française d'Addictologie (SFA): Note: SF2A is itself the rebranded successor. The broader Société Française d'Addictologie is a French learned society spanning all addictive behaviors. Comparable overlap in mission, French audience, and policy advocacy on addiction.

Others

• EMCDDA (European Monitoring Centre for Drugs and Drug Addiction): EU agency providing epidemiological data and policy analysis on drugs and addiction. Comparable as a Europe-level knowledge hub whose reports and data inform SF2A's research and advocacy work.
• NIAAA (National Institute on Alcohol Abuse and Alcoholism): U.S. federal agency on alcohol research, listed as a SF2A partner on the harmonization of research metrics on alcohol use. Comparable as a primary scientific authority whose work SF2A translates into the French context.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/soci%C3%A9t%C3%A9-fran%C3%A7aise-d-alcoologie

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Société Française d'Alcoologie